Sex hormones, proto-oncogene expression and apoptosis: Their effects on rheumatoid synovial tissue

Clinical and Experimental Rheumatology

Volumn 14, Issue 1, 1996, Pages 87-94

  Cutolo, M ^a   Sulli, A ^a   Barone, A ^a   Seriolo, B ^a   Accardo, S ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

apoptosis; proto oncogenes; rheumatoid arthritis; sex hormones; synovial tissue

Indexed keywords

SEX HORMONE;

ANIMAL TISSUE; APOPTOSIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; GENE EXPRESSION; GONADAL STEROID HORMONES; HUMANS; PROTO-ONCOGENES; SYNOVIAL FLUID;

EID: 0029878065     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. CARSON DA, RIBEIRO JM: Apoptosis and disease. Lancet 1993; 341: 1251-4.
2. BISHOP MJ: Cellular oncogenes and retroviruses. Ann Rev Biochem 1983; 52: 301-54.
3. CUTOLO M, SULLI A, SERIOLO B, ACCARDO S, MASI AT: Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13: 217-26.
4. CUTOLO M, ACCARDO S, VILLAGGIO B, BARONE A, SULLI A, COVIELLO DA, CARABBIO C, FELLI L, MICELI D, FARRUGGIO D, CARRUBA G, CASTAGNETTA L: Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81 (in press).
5. WYLLIE AH, KERR JF, CURRIE AR: Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
6. KERR JF, WYLLIE AH, CURRIE AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
7. HSUEH AJW, BILLING H, TSAFRIRI A: Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994; 15: 707-24.
8. SCHWARTZMAN RA, CIDLOWSKI JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 1993; 14: 133-51.
9. BAKER TG: A quantitative and cytological study of germ cells in the human ovaries.Proc R Soc Lond (Biol) 1963; 158: 417-33.
10. TILLY JL, KOWALSKI KI, JOHNSON AL, HSUEH AJW: Involvement of apoptosis in ovarian follicle atresia and post-ovulatory regression. Endocrinology 1991; 129: 2799-801.
11. ADASHI EY, RESNICK CE, RICCIARELLI E, HURWITZ A, KOKIA E, TEDESCHI C, BOTERO L, HERNANDEZ ER, ROSENFELD RG, CARLSSON-SKWIRUT C: Granulosa cell-derived insulin-like growth factor (IGF) binding proteins. J Clin Invest 1992; 90: 1593-9.
12. AZZOLIN GC, SAIDUDDIN S: Effect of androgens on ovarian morphology of the hypophysectomized rat. Proc Soc Exp Biol Med 1983; 172: 70-3.
13. ZELEZNIK AJ, HILLIER SG, ROSS GT: Follicle stimulating hormone-induced follicular development: an examination of the role of the androgens. Biol Reprod 1979; 21: 673-81.
14. BILLING H, FURUTA I, HSUEH AJW: Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1993; 133: 2204-12.
15. MOOR RM, DOTT HM, CRAN DG: Macroscopic identification and steroidogenic function of atretic follicles in sheep. J Endocrinol 1978; 77: 309-18.
16. KLAS C, DEBATIN KM, JONKER RR, KRAMMER PH: Activation interferes with the APO-I pathway in mature human T cells. Int lmmunol 1993; 5: 625-30.
17. OSTERMANN J, HORWICH AL, NEUPERT W, HARTL FU: Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis. Nature 1989; 341: 125-30.
18. KAUFMANN SHE: Heat shock proteins and the immune response. Immunol Today 1990; 11: 129-36.
19. KLINMAN DM, MUSHINSKI JF, HONDA M, ISHIGATSUBO Y, MOUNTZ JD, RAVECHE ES, STEINBERG AD: Oncogene expression in autoimmune and normal peripheral blood mononuclear cells. J Exp Med 1986; 163: 1292-307.
20. SCHONTHAL A, HERRLICH P, RAHMSDORF HJ: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988; 54: 325-44.
21. COHEN SS: Exponential growth in apoptosis. Immunol Today 1995; 16: 346-8.
22. HOCKENBERG DM, NUNEZ G, MILLIMAN C, SCHREIBER RD, KORSMEYER SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
23. MOUNTZ JD, WU J, CHENG J, ZHOU T: Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 1994; 37: 1415-20.
24. HOCKENBERG DM, OLTVAI ZN, YIN XM, MILLLAM CL, KORSMEYER SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51.
25. YONISH-ROUACH E, RESNITSKY D, LOTEM J, SACHS L, KIMCHI A, OREN L: Wild type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 1991; 353: 345-7.
26. CASCIOLA-ROSEN LA, ABHALT G, ROSEN A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-30.
27. WEISZ A, ROSALES R Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acid Res 1990; 18: 5097-106.
28. WEBB P, LOPEZ GN, UHT RM, KUSHNER PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of anti-estrogens. Mol Endocrinol 1995; 9: 443-56.
29. MURPHY LJ, MURPHY LC, FREISEN HG: Estrogen induction of n-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology 1987; 120: 1882-8.
30. LOOSE-MITCHELL DS, CHIAPPETTA C, STANCEL GM: Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 1988; 2: 946-51.
31. HARRIS SA, SUBRAMAMIAM M, RIGGS BL, SPELSBERG TC: Estrogen induces c-fos promoter activity in normal human osteoblast-like cells. J Bone Min Res 1992; 7 (suppl): 7.
32. WEISZ A, CICATIELLO L, PERSICO E, SCALONA M, BRESCIANI F: Estrogen stimulates transcription of c-jun proto-oncogene. Mol Endocrinol 1990; 4: 1041-50.
33. QUARMBY VE, BECKMAN WC, WILSON EM, FRENCH FS: Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate. Mol Endocrinol 1987; 1: 865-74.
34. WOLF DA, KOHLHUBER F, SCHULTZ P, FITTLER F, EICK D: Transcriptional down-regulation of c-myc in human prostate carcinoma cells by synthetic androgen mibolerone. Br J Cancer 1992; 65: 376-82.
35. NAKAJIAMA T, AONO H, HASUNUMA T, YAMAMOTO K, SHIRAI T, HIROHATA K, NISHIOKA K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995; 38: 485-91.
36. FIRESTEIN GS, YEO M, ZVAIFLER NJ. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995; 96: 1631-8.
37. WU J, ZHOU T, MOUNTZ JD: Autoimmune disease in mice due to integration of an endogenous retro virus in an apoptosis gene. J Exp Med 1993; 178: 461-8.
38. TANAKA A, O'SULLIVAN FX, KOOPMAN WJ, GAY S: Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/ lpr mice. Ultrastructural basis of joint destruction. J Rheumatol 1988; 15: 10-6.
39. KUROKI Y, SHIOZAWA S, YOSHIHARA R, HOTTA H: The contribution of human c-fos DNA to cultured synovial cells: a transfection study. J Rheumatol 1993; 20: 422-8.
40. TRABANDT A, AICHER WK, GAY RE: Expression of the collagenolytic and ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/1 mice and patients with rheumatoid arthritis. Matrix 1990; 10: 349-61.
41. VUORIO E, DE CROMBRUGGHE B: The family of collagen genes. Annu Rev Biochem 1990; 59: 837-72.
42. KINNE RW, BOEHM S, IFTER T, AIGNER T, VORNEHM S, WESELOH G, BRAVO R, EMMRICH F, KROCZEK RA: Synovial fibroblast-like cells strongly express jun-b and c-fos proto-oncogenes in rheumatoid and osteoarthritis. Scand J Immunol 1995; 24: 121-5.
43. MULLER-LADNER U, KRIEGSMANN J, GAY RE: Upregulation of bcl-2 mRNA in synovium of patients with rheumatoid arthritis. Arthritis Rheum 1994; 37: S163-26.
44. TAN EM: Autoimmunity and apoptosis. J Exp Med 1994; 179: 1083-6.
45. ARINGER M, WINTERSBERGER W, STEINER C, KIENER H, PRESTEREL E, JAEGER U, SMOLEN JS, GRANINGER WB: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1423-30.
46. ROSE LM, LATCHMAN DS, ISENBERG DA: Bcl-2 expression is unaltered in unfractioned peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Br J Rheumatol 1995; 34: 316-20.
47. ICHIKAWA Y, ARIMORI K, YOSHIDA M, HORIKI T, HOSHINA Y, MORITA K, UCHIYAMA M, SHMIZU H, MORIUCHI J, TAKAYA M: Abnormal expression of apoptosis-related antigens. Fas and bcl-2 on circulating T lymphocyte subsets in primary Sjögren's syndrome. Clin Exp Rheumatol 1995; 13: 307-13.
48. CUTOLO M, BALLEARI E, GIUSTI M, MONACHESI M, ACCARDO S: Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988; 31: 1314-7.
49. MASI AT, JOSIPOVIC DB, JEFFERSON WE: Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic (GLC) studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984; 14: 1-23.
50. HEDMAN M, NILSSON E, DE LA TORRE B: Low blood and synovial fluid levels of sulphoconjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992; 10: 25-30.
51. CUTOLO M, SULLI A, BARONE A, SERIOLO B, ACCARDO S: Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 1993; 11: 331-9.
52. MUNN DH, BEALL AC, SONG D, WRENN RW, THROCKMORTON C: Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and imerfeion γ. J Exp Med 1995; 181: 127-36.
53. CUTOLO M, ACCARDO S, VILLAGGIO B, CLERICO P, INDIVERI F, CARRUBA G, FECAROTTA E, CASTAGNETTA L: Evidence for androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992; 35: 1007-15.
54. CUTOLO M, ACCARDO S, VILLAGGIO B, CLERICO P, BAGNASCO M, COVIELLO D. CARRUBA G, FECAROTTA E, CASTAGNETTA L: Presence of estrogen binding sites in macrophage-like synoviocytes and CD8+CD29+CD45RO+ T lymphocytes in normal and rheumatoid synovia. Arthritis Rheum 1993; 36: 1087-97.
55. SORRENTINO V, DROZDOFF V, MCKINNEY MD: Potentiation of growth factor activity by exogenous c-myc expression. Proc Natl Acad Sci USA 1986; 83: 8167-71.
56. WEISZ A, BRESCIANI F: Estrogen induces expression of c-fos and c-myc proto-oncogens in rat uterus. Mol Endocrinol 1988; 2: 816-24.
57. KENNEDY AR: Prevention of carcinogenesis by protease inhibitors. Cancer Res 1994; 54: 1999S-2005S.
58. MÜLLER-LADNER U, KRIESGMANN J, GAY RE, GAY S: Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 675-91.